表紙
市場調查報告書
商品編碼
1083090

輸卵管癌治療藥的全球市場(2022年∼2026年)

Global Fallopian Tube Cancer Therapeutics Market 2022-2026

出版日期: | 出版商: TechNavio (Infiniti Research Ltd.) | 英文 120 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球輸卵管癌治療藥的市場規模在2022年∼2026年間,預測將成長到6億2,800萬美元,在預測期間內預計將以年複合成長率9.06%成長。

市場成長的主要因素有針對女性健康的關心提升,強大的藥物批准和戰略聯盟。

本報告提供全球輸卵管癌治療藥市場相關調查分析,網羅整體分析,市場規模·預測,趨勢,成長促進因素,課題,及約25家供應商分析。

目錄

第1章 摘要整理

  • 市場概要

第2章 市場形勢

  • 市場生態系統

第3章 市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模:2021年
  • 市場預測:2021年∼2026年的預測

第4章 波特的五力分析

  • 五力的摘要
  • 買方議價能力
  • 供給企業談判力
  • 新加入廠商業者帶來的威脅
  • 替代品帶來的威脅
  • 對手業者帶來的威脅
  • 市場情況

第5章 市場區隔:各產品

  • 市場區隔
  • 比較:各產品
  • 標靶治療 - 市場規模與預測(2021年∼2026年)
  • 化療 - 市場規模與預測(2021年∼2026年)
  • 市場機會:各產品

第6章 客戶形勢

  • 概要

第7章 各地區形勢

  • 地區市場區隔
  • 地區比較
  • 北美 - 市場規模與預測(2021年∼2026年)
  • 歐洲 - 市場規模與預測(2021年∼2026年)
  • 亞洲 - 市場規模與預測(2021年∼2026年)
  • 其他地區 - 市場規模與預測(2021年∼2026年)
  • 美國 - 市場規模與預測(2021年∼2026年)
  • 奧地利 - 市場規模與預測(2021年∼2026年)
  • 中國 - 市場規模與預測(2021年∼2026年)
  • 瑞士 - 市場規模與預測(2021年∼2026年)
  • 印度 - 市場規模與預測(2021年∼2026年)
  • 市場機會:各地區形勢

第8章 促進因素,課題,及趨勢

  • 推動市場要素
  • 市場課題
  • 推動因素與課題的影響
  • 市場趨勢

第9章 業者情勢

  • 概要
  • 業者情勢
  • 混亂狀況
  • 產業的風險

第10章 供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Amgen Inc.
  • Baxter International Inc.
  • Bristol Myers Squibb Co.
  • Clovis Oncology Inc.
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • ImmunoGen Inc.
  • Johnson and Johnson
  • Merck and Co. Inc.

第11章 附錄

目錄
Product Code: IRTNTR73559

Technavio has been monitoring the fallopian tube cancer therapeutics market and it is poised to grow by $ 628.28 mn during 2022-2026, accelerating at a CAGR of 9.06% during the forecast period. Our report on the fallopian tube cancer therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing attention toward women's health, an array of strong drug approvals, and strategic alliances.

The fallopian tube cancer therapeutics market analysis includes product segment and geographic landscape.

Technavio's fallopian tube cancer therapeutics market is segmented as below:

By Product

  • Targeted therapy
  • Chemotherapy

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the growing research on regenerative therapies as one of the prime reasons driving the fallopian tube cancer therapeutics market growth during the next few years. Also, advent of treatment vaccines for cancer and growing usage of nanotechnology for effective treatment will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on fallopian tube cancer therapeutics market covers the following areas:

  • Fallopian tube cancer therapeutics market sizing
  • Fallopian tube cancer therapeutics market forecast
  • Fallopian tube cancer therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading fallopian tube cancer therapeutics market vendors that include AbbVie Inc., Amgen Inc., Baxter International Inc., Bristol Myers Squibb Co., Clovis Oncology Inc., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, ImmunoGen Inc., Johnson and Johnson, Merck and Co. Inc., and Novartis AG. Also, the fallopian tube cancer therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

  • 5.1 Market segments
  • Exhibit 24: Chart on Product - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
  • 5.2 Comparison by Product
  • Exhibit 26: Chart on Comparison by Product
  • Exhibit 27: Data Table on Comparison by Product
  • 5.3 Targeted therapy - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Targeted therapy - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on Targeted therapy - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on Targeted therapy - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Targeted therapy - Year-over-year growth 2021-2026 (%)
  • 5.4 Chemotherapy - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Chemotherapy - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Chemotherapy - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Chemotherapy - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Chemotherapy - Year-over-year growth 2021-2026 (%)
  • 5.5 Market opportunity by Product
  • Exhibit 36: Market opportunity by Product ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 40: Chart on Geographic comparison
  • Exhibit 41: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Austria - Market size and forecast 2021-2026
  • Exhibit 62: Chart on Austria - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on Austria - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on Austria - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on Austria - Year-over-year growth 2021-2026 (%)
  • 7.9 China - Market size and forecast 2021-2026
  • Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.10 Switzerland - Market size and forecast 2021-2026
  • Exhibit 70: Chart on Switzerland - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on Switzerland - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on Switzerland - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on Switzerland - Year-over-year growth 2021-2026 (%)
  • 7.11 India - Market size and forecast 2021-2026
  • Exhibit 74: Chart on India - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on India - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on India - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on India - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 81: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 82: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 83: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 84: Matrix on vendor position and classification
  • 10.3 Amgen Inc.
  • Exhibit 85: Amgen Inc. - Overview
  • Exhibit 86: Amgen Inc. - Product / Service
  • Exhibit 87: Amgen Inc. - Key offerings
  • 10.4 Baxter International Inc.
  • Exhibit 88: Baxter International Inc. - Overview
  • Exhibit 89: Baxter International Inc. - Business segments
  • Exhibit 90: Baxter International Inc. - Key news
  • Exhibit 91: Baxter International Inc. - Key offerings
  • Exhibit 92: Baxter International Inc. - Segment focus
  • 10.5 Bristol Myers Squibb Co.
  • Exhibit 93: Bristol Myers Squibb Co. - Overview
  • Exhibit 94: Bristol Myers Squibb Co. - Product / Service
  • Exhibit 95: Bristol Myers Squibb Co. - Key offerings
  • 10.6 Clovis Oncology Inc.
  • Exhibit 96: Clovis Oncology Inc. - Overview
  • Exhibit 97: Clovis Oncology Inc. - Business segments
  • Exhibit 98: Clovis Oncology Inc. - Key offerings
  • Exhibit 99: Clovis Oncology Inc. - Segment focus
  • 10.7 Eli Lilly and Co.
  • Exhibit 100: Eli Lilly and Co. - Overview
  • Exhibit 101: Eli Lilly and Co. - Product / Service
  • Exhibit 102: Eli Lilly and Co. - Key offerings
  • 10.8 F. Hoffmann La Roche Ltd.
  • Exhibit 103: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 104: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 105: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 106: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 107: F. Hoffmann La Roche Ltd. - Segment focus
  • 10.9 GlaxoSmithKline Plc
  • Exhibit 108: GlaxoSmithKline Plc - Overview
  • Exhibit 109: GlaxoSmithKline Plc - Business segments
  • Exhibit 110: GlaxoSmithKline Plc - Key news
  • Exhibit 111: GlaxoSmithKline Plc - Key offerings
  • Exhibit 112: GlaxoSmithKline Plc - Segment focus
  • 10.10 ImmunoGen Inc.
  • Exhibit 113: ImmunoGen Inc. - Overview
  • Exhibit 114: ImmunoGen Inc. - Product / Service
  • Exhibit 115: ImmunoGen Inc. - Key offerings
  • 10.11 Johnson and Johnson
  • Exhibit 116: Johnson and Johnson - Overview
  • Exhibit 117: Johnson and Johnson - Business segments
  • Exhibit 118: Johnson and Johnson - Key news
  • Exhibit 119: Johnson and Johnson - Key offerings
  • Exhibit 120: Johnson and Johnson - Segment focus
  • 10.12 Merck and Co. Inc.
  • Exhibit 121: Merck and Co. Inc. - Overview
  • Exhibit 122: Merck and Co. Inc. - Business segments
  • Exhibit 123: Merck and Co. Inc. - Key news
  • Exhibit 124: Merck and Co. Inc. - Key offerings
  • Exhibit 125: Merck and Co. Inc. - Segment focus

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 126: Inclusions checklist
  • Exhibit 127: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 128: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 129: Research methodology
  • Exhibit 130: Validation techniques employed for market sizing
  • Exhibit 131: Information sources
  • 11.5 List of abbreviations
  • Exhibit 132: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Product - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Product - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Product
  • Exhibits27: Data Table on Comparison by Product
  • Exhibits28: Chart on Targeted therapy - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on Targeted therapy - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on Targeted therapy - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Targeted therapy - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Chemotherapy - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on Chemotherapy - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on Chemotherapy - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Chemotherapy - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Market opportunity by Product ($ million)
  • Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits40: Chart on Geographic comparison
  • Exhibits41: Data Table on Geographic comparison
  • Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on Austria - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on Austria - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on Austria - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on Austria - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on Switzerland - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on Switzerland - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on Switzerland - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on Switzerland - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on India - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on India - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on India - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on India - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Market opportunity By Geographical Landscape ($ million)
  • Exhibits79: Impact of drivers and challenges in 2021 and 2026
  • Exhibits80: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits81: Overview on factors of disruption
  • Exhibits82: Impact of key risks on business
  • Exhibits83: Vendors covered
  • Exhibits84: Matrix on vendor position and classification
  • Exhibits85: Amgen Inc. - Overview
  • Exhibits86: Amgen Inc. - Product / Service
  • Exhibits87: Amgen Inc. - Key offerings
  • Exhibits88: Baxter International Inc. - Overview
  • Exhibits89: Baxter International Inc. - Business segments
  • Exhibits90: Baxter International Inc. - Key news
  • Exhibits91: Baxter International Inc. - Key offerings
  • Exhibits92: Baxter International Inc. - Segment focus
  • Exhibits93: Bristol Myers Squibb Co. - Overview
  • Exhibits94: Bristol Myers Squibb Co. - Product / Service
  • Exhibits95: Bristol Myers Squibb Co. - Key offerings
  • Exhibits96: Clovis Oncology Inc. - Overview
  • Exhibits97: Clovis Oncology Inc. - Business segments
  • Exhibits98: Clovis Oncology Inc. - Key offerings
  • Exhibits99: Clovis Oncology Inc. - Segment focus
  • Exhibits100: Eli Lilly and Co. - Overview
  • Exhibits101: Eli Lilly and Co. - Product / Service
  • Exhibits102: Eli Lilly and Co. - Key offerings
  • Exhibits103: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits104: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits105: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits106: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits107: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits108: GlaxoSmithKline Plc - Overview
  • Exhibits109: GlaxoSmithKline Plc - Business segments
  • Exhibits110: GlaxoSmithKline Plc - Key news
  • Exhibits111: GlaxoSmithKline Plc - Key offerings
  • Exhibits112: GlaxoSmithKline Plc - Segment focus
  • Exhibits113: ImmunoGen Inc. - Overview
  • Exhibits114: ImmunoGen Inc. - Product / Service
  • Exhibits115: ImmunoGen Inc. - Key offerings
  • Exhibits116: Johnson and Johnson - Overview
  • Exhibits117: Johnson and Johnson - Business segments
  • Exhibits118: Johnson and Johnson - Key news
  • Exhibits119: Johnson and Johnson - Key offerings
  • Exhibits120: Johnson and Johnson - Segment focus
  • Exhibits121: Merck and Co. Inc. - Overview
  • Exhibits122: Merck and Co. Inc. - Business segments
  • Exhibits123: Merck and Co. Inc. - Key news
  • Exhibits124: Merck and Co. Inc. - Key offerings
  • Exhibits125: Merck and Co. Inc. - Segment focus
  • Exhibits126: Inclusions checklist
  • Exhibits127: Exclusions checklist
  • Exhibits128: Currency conversion rates for US$
  • Exhibits129: Research methodology
  • Exhibits130: Validation techniques employed for market sizing
  • Exhibits131: Information sources
  • Exhibits132: List of abbreviations